secukinumab,adalimumab
novartis,abbvie
['adalimumab', 'axspa', 'secukinumab']
new data #acr22 abstract no difference in radiographic progression between secukinumab and adalimumab biosimilar over 2 years presented by #axspa
Rheumatologist | Physician |  Portsmouth Hospitals University NHS Trust UK | Views my own | Re-tweets do not mean endorsement | Mainly clinical news/updates